康泰生物 (300601.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(康泰生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 451,659,438.753,477,438,725.182,464,464,778.621,730,568,886.34748,383,301.393,157,401,754.792,565,064,078.161,827,843,901.50871,425,498.86
 营业利润(元) 69,940,162.05948,916,417.90768,749,273.17566,356,417.92244,347,202.88-317,570,999.76152,588,734.4888,241,827.86327,201,104.05
 利润总额(元) 65,159,072.40940,319,861.96765,002,501.60563,760,501.86241,818,059.26-338,246,462.39143,273,316.0684,591,706.88322,000,412.25
 净利润(元) 54,028,967.57861,303,903.06697,050,864.48510,431,517.35205,462,820.25-132,707,859.29203,147,096.43120,502,824.15273,588,319.57
 归属于母公司股东的净利润(元) 54,065,937.45861,303,903.06697,050,864.48510,431,517.35205,462,820.25-132,707,859.29203,147,096.43120,502,824.15273,588,319.57
盈利能力:
 销售毛利率(%) 84.0784.5486.0586.7585.9184.1787.0286.6885.96
 销售净利率(%) 11.9624.7728.2829.5027.45-4.207.926.5931.40
 净资产收益率(%) 0.589.307.385.482.15----
 总资产报酬率ROA(%) 0.486.505.344.011.69----
 投入资本回报率ROIC(%) 0.447.335.934.381.79-1.141.721.022.25
营运能力:
 存货周转率(次) 0.090.720.410.260.11----
 应收账款周转率(次) 0.171.370.980.700.34----
 总资产周转率(次) 0.030.240.170.120.05----
偿债能力:
 资产负债率(%) 35.9536.7534.9434.2634.1534.8232.8832.8630.63
 股东权益比率(%) 64.0563.2565.0665.7465.8565.1867.1267.1469.37
 已获利息倍数(倍) 15.13-601.93-403.42-411.72-104.8616.99-5.63-3.62-42.87
 流动比率 1.821.962.152.282.322.212.773.103.53
 速动比率 1.451.631.741.891.891.822.312.592.92
发展能力:
 营业收入增长率(%) -39.6510.14-3.92-5.32-14.12-13.557.9073.72214.60
 营业利润增长率(%) -71.38398.80403.80541.82-25.32-121.87-87.25-77.241,004.86
 税后利润增长率(%) -73.69749.02243.13323.58-24.90-110.50-80.40-64.19987.71
 净资产增长率(%) 5.856.192.961.64-9.37-1.983.1115.7332.37
 总资产增长率(%) 8.819.426.233.80-4.53-2.564.2625.8845.01

前瞻产业研究院